Quick Answer
IRADIMED CORP reported Research And Development Expense of $2.98 million for the year ending 2025.
- IRADIMED CORP showed an increase of +5.0% in Research And Development Expense from 2024 to 2025.
- This data is from IRADIMED CORP's annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), IRADIMED CORP's Research And Development Expense has grown by 194.6%.
- Historical annual values: Fiscal year 2025: $2.98 million | Fiscal year 2024: $2.83 million | Fiscal year 2023: $2.86 million | Fiscal year 2022: $2.28 million | Fiscal year 2021: $1.91 million | Fiscal year 2020: $1.90 million | Fiscal year 2019: $1.43 million | Fiscal year 2018: $1.52 million | Fiscal year 2017: $1.72 million | Fiscal year 2016: $1.35 million | Fiscal year 2015: $1.76 million | Fiscal year 2014: $1.07 million | Fiscal year 2013: $1.01 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: